US 12,258,321 B1
Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer
Roaa M. Alreemi, Jeddah (SA); Hind A. Alkhatabi, Jeddah (SA); Mohammed A. Baradwan, Jeddah (SA); Abdelsattar M. Omar, Jeddah (SA); Moustafa E. El-Araby, Cairo (EG); Yara E. Mansour, Cairo (EG); Samar S. Fatahala, Cairo (EG); Ahmed M. Said, Cairo (EG); and Shahenda Mahgoub, Cairo (EG)
Assigned to University of Jeddah, Jeddah (SA); King Abdulaziz University, Cairo (EG); and Helwan University, Cairo (EG)
Filed by Roaa M. Alreemi, Jeddah (SA); Hind A. Alkhatabi, Jeddah (SA); Mohammed A. Baradwan, Jeddah (SA); Abdelsattar M. Omar, Jeddah (SA); Moustafa E. El-Araby, Cairo (EG); Yara E. Mansour, Cairo (EG); Samar S. Fatahala, Cairo (EG); Ahmed M. Said, Cairo (EG); and Shahenda Mahgoub, Cairo (EG)
Filed on Oct. 14, 2024, as Appl. No. 18/914,691.
Int. Cl. C07D 249/06 (2006.01); A61K 31/4192 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); C07D 405/12 (2006.01)
CPC C07D 249/06 (2013.01) [A61K 31/4192 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07D 405/12 (2013.01)] 6 Claims
 
1. A compound of formula (I)

OG Complex Work Unit Chemistry
or a salt thereof or a composition thereof,
wherein R is a group selected from the group consisting of alkyl, alkoxy, alkylamino, alkylthio, phenyl, phenoxy, phenylamino, phenylthiol, hydroxy, amino, aralkyl, heterocyclic, amidic, ureidic, carboxylic sulfonamido, or ester, and wherein the group is optionally substituted with an alkyl, aryl, alkoxy, nitrile, nitro, or halo group.